Product Information
LANSOPRAZOLE DR 15 MG CAPSULE is a generic product labeled by Rugby Laboratories, priced at $0.4067 per EA under NDC 00536136813. Its NADAC has been published 163 times since Aug 23, 2023.
FDA first approved this application on May 18, 2012.
Strength
15 mg/1
Manufacturer
Rugby LaboratoriesNDC
00536136813
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LANSOPRAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA202194FDA Approved
5/18/2012
On Market Since
10/26/2022
Pharmacological Classes
Price Statistics
The NADAC for LANSOPRAZOLE DR 15 MG CAPSULE has been published 163 times since Aug 23, 2023, and over the history we have for it it has declined 9.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4067 per EA |
|---|---|
| All-time high | $0.4918 (Jul 10, 2024) |
| All-time low | $0.3778 (Oct 18, 2023) |
| 52-week high | $0.4629 |
| 52-week low | $0.4067 |
| Median price | $0.4401 |
| Average price | $0.4402 |
| Largest weekly change | -19.6% (Oct 18, 2023) |
| Weeks tracked | 163 |
| Tracking since | Aug 23, 2023 |
Generic Alternatives
The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 64% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rugby Laboratories manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lansoprazole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Proton Pump Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LANSOPRAZOLE DR 15 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for LANSOPRAZOLE DR 15 MG CAPSULE, manufactured by Rugby Laboratories, is $0.4067 per EA (NDC 00536136813), effective Sep 30, 2026.
How has the price of LANSOPRAZOLE DR 15 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for LANSOPRAZOLE DR 15 MG CAPSULE has declined 9.9%. It has been tracked across 163 weekly CMS publications since Aug 23, 2023.
What are the highest and lowest recorded NADAC prices for LANSOPRAZOLE DR 15 MG CAPSULE?
Since Aug 23, 2023, the NADAC for LANSOPRAZOLE DR 15 MG CAPSULE has ranged from a low of $0.3778 (Oct 18, 2023) to a high of $0.4918 (Jul 10, 2024), with a median of $0.4401 per EA.
Are there cheaper alternatives to LANSOPRAZOLE DR 15 MG CAPSULE?
Yes. 12 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LANSOPRAZOLE DR 15 MG CAPSULE, is $0.1474 per EA — about 64% below LANSOPRAZOLE DR 15 MG CAPSULE.
Who manufactures LANSOPRAZOLE DR 15 MG CAPSULE?
LANSOPRAZOLE DR 15 MG CAPSULE (NDC 00536136813) is labeled by Rugby Laboratories, and CMS classifies it as a generic product.